Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.8775
|
0.895
|
0.803
|
0.803
|
0.803
|
0.803
|
|
|
|
|
0.8045
|
0.8205
|
0.803
|
0.803
|
0.803
|
0.803
|
|
|
|
|
0.75
|
0.765
|
0.7495
|
0.7495
|
0.7495
|
0.7495
|
|
|
|
|
0.752
|
0.7665
|
0.7495
|
0.7495
|
0.7495
|
0.7495
|
|
|
|
|
0.7505
|
0.7655
|
0.724
|
0.724
|
0.724
|
0.724
|
|
|
|
|
0.705
|
0.719
|
0.7465
|
0.7465
|
0.7465
|
0.7465
|
|
|
|
|
0.7555
|
0.7705
|
0.701
|
0.701
|
0.701
|
0.701
|
|
|
|
|
0.686
|
0.6995
|
0.702
|
0.702
|
0.702
|
0.702
|
|
|
|
|
0.6885
|
0.702
|
0.702
|
0.702
|
0.702
|
0.702
|
|
|
|
|
0.679
|
0.692
|
0.7045
|
0.7045
|
0.7045
|
0.7045
|
|
|
|
|
Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States.